Nome Químico: N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(1-oxido-2-pyridinyl)-β-alanine ethyl ester ;
Sorrisos: CN1C2=CC=C(C(N(C3=CC=CC=[N]3=O)CCC(OCC)=O)=O)C=C2N=C1CNC4=CC=C(C(NC(OCCCCCC)=O)=N)C=C4
Inchi: InChI=1S/C20H22N6O3/c1-26-16-7-4-13(20(29)23-9-8-18(27)28)10-15(16)25-17(26)11-24-14-5-2-12(3-6-14)19(21)22/h2-7,10,24H,8-9,11H2,1H3,(H3,21,22)(H,23,29)(H,27,28)
Novel method for separation and quantification of potential impurities by RP-HPLC from KSM stage to API stage of dabigatran mesylate
By Jhansi, T. Naga; Nagaraju, R.; Kumar, D. Jaya Deep; Rao, G. Nageswara
From International Journal of Pharmaceutical Sciences and Research (2021), 12(3), 1762-1779
Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column
By Mantena, Bhaskara P. V.; Rao, Sumathi V.; Suryakala, D.; Ramakrishna, K.; Srikanth Reddy, R.
From Analytical Chemistry Letters (2016), 6(5), 595-611
Determination of dabigatran etexilate mesylate by HPLC
By Jia, Ling-xiao; Tang, Lei; Zhang, Shu-ting; Song, Rui-zhi; Gao, Zhan-wen
From Shipin Yu Yaopin (2015), 17(3), 195-197